4//SEC Filing
Ohana Patricia 4
Accession 0001140361-11-015161
CIK 0001451980other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:16 PM ET
Size
5.5 KB
Accession
0001140361-11-015161
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Ohana Patricia
VP of Clinical Development
Transactions
- Award
Employee Options
2011-03-06+70,888→ 290,888 totalExp: 2021-03-06→ Common Stock (70,888 underlying)
Footnotes (2)
- [F1]The exercise price is 2.85 NIS per share.
- [F2]An option to purchase 13,293 shares shall be exercisable immediately, and an option to purchase 4,431 shares shall be exercisable at the end of each calendar quarter, from March 31, 2011 until March 31, 2014.
Documents
Issuer
BIOCANCELL THERAPEUTICS INC.
CIK 0001451980
Entity typeother
Related Parties
1- filerCIK 0001466922
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:16 PM ET
- Size
- 5.5 KB